Russell Alan J. - 26 Dec 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Scientific Officer, Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Russell Alan J
Issuer symbol
EWTX
Transactions as of
26 Dec 2023
Net transactions value
-$1,610,097
Form type
4
Filing time
28 Dec 2023, 16:38:37 UTC
Previous filing
18 Aug 2023
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Sale $1,610,097 -172,585 -98% $9.33 3,606 26 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price.